medigraphic.com
SPANISH

Acta Pediátrica de México

Órgano Oficial del Instituto Nacional de Pediatría
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2019, Number 1

<< Back Next >>

Acta Pediatr Mex 2019; 40 (1)

Facial Tinea incognito. Case report

Lizardo-Castro G, Cerrato-Hernández K, Cruz-Enamorado B
Full text How to cite this article

Language: Spanish
References: 21
Page: 22-27
PDF size: 563.12 Kb.


Key words:

Tinea incognito, Dermatophytic infection, Steroids, Calcineurin inhibitors, Self-medication.

ABSTRACT

Background: Tinea incognito is defined as a dermatophytic infection with a modified morphology due to the inappropriate application of topical or oral steroids or calcineurin inhibitors. This problem occurs more often in cases of facial tinea and may be a diagnostic challenge that requires a good clinical history, physical examination and complementary laboratory tests. In tropical developing countries, like Honduras, dermatophytoses are a prevalent problem due to multiple factors: warm climate, overcrowding, contact with animals and poor hygiene habits; also over-the-counter sale of medications favors self-medication and lack of availability of laboratory tests in most public health care centers makes difficult to confirm the diagnosis.
Clinical cases: We reporting two cases of facial tinea incognito in female pediatric patients due to Trichophyton verrucosum treated with combined oral and topical therapy with good results.
Conclussion: We want to raise the awareness of health professionals about the risk of inappropriate use of steroids and calcineurin inhibitors, especially in facial dermatoses.


REFERENCES

  1. Arenas R, Moreno-Coutiño G, Vera L, Welsh O. Tinea incognito. Clin dermatol. 2010;28(2):137-9.

  2. Del Boz J, Cresco V, Rivas Ruiz F, Troya M. Tinea incognito: 54 cases. Mycoses. 2011;54:254-8.

  3. Kim WJ, Kim TW, Mun JH, Song M, Kim HS, Ko HC, et al. Tinea incognito in Korea and its risk factors: nine-year multicenter survey. J Korean Med Sci. 2013;28(1):145-51.

  4. Urbina F, Sudy E, Barrios M. Tiña incógnita. Piel. 2002;17(1):12-7.

  5. Ansar A, Farshchian M, Nazeri H, Ghiasian SA. Clinicoepidemiological and mycological aspects of tinea incognito in Iran: a 16-year study. Med Mycol J. 2011;52(1):25-32.

  6. Padilla-Desgarennes MD, Morales-Sánchez MA, Lazo-García EC. Epidemiología de la tiña incógnita en el Centro Dermatológico Dr. Ladislao de la Pascua. Rev Cent Dermatol Pascua. 2014;23(3):85-9.

  7. Sánchez-Saldaña L, Matos-Sánchez R, Kumakawa H. Infecciones micóticas superficiales. Dermatol Peru. 2009;19(3):226-66.

  8. Sharma V, Kumawat TK, Sharma A, Seth R, Chandra S. Dermatophytes: Diagnosis of dermatophytosis and its treatment. Afr J Microbiol. 2015; 9(19):1286-93.

  9. Ruiz-Rivero J, Mendoza-Cembranos MD, Ciudad Blanco MC. Tiña incógnita: serie de casos y revisión bibliográfica. Piel. 2014;29:624-7.

  10. Nieto-Rodríguez D, Gómez-Fernández C, Rueda-Carnero JM. Tinea incognito: A Challenging Entity. J Fam Med. 2017;4(1): 1103.

  11. Moriarty B, Hay R, Morris-Jones R. The diagnosis and management of tinea. BMJ. 2012 Jul 10;345:e4380. doi: 10.1136/bmj.e4380

  12. Lin RL, Szepietowski JC, Schwartz RA. Tinea faciei, an oftendeceptive facial eruption. Int J Dermatol. 2004; 43:437-40.

  13. Romano C, Maritati E, Gianni C. Tinea incognito in Italy: a 15 years survey. Mycoses. 2006;49(5):383-7.

  14. Dutta B, Rasul ES, Boro B. Clinico-epidemiological study of tinea incognito with microbiological correlation. Indian J Dermatol Venereol Leprol. 2017;83:326-31.

  15. Lange M, Jasiel‐Walikowska E, Nowicki R, Bykowska B. Tinea incognito due to Trichophyton mentagrophytes. Mycoses. 2010;53(5):455-7.

  16. Seitz AT, Paasch U, Simon JC, Ziemer M. Tinea incognito. JDDG. 2013; 11:1090-3.

  17. Gomez-Moyano E, Crespo-Erchiga V, Martinez-Pilar L, Martinez-García S. Correlation between dermoscopy and direct microscopy of morse code hairs in tinea incognito. JAAD. 2016;74(1): e7-8.

  18. Navarrete‐Dechent C, Bajaj S, Marghoob AA, Marchetti MA. Rapid diagnosis of tinea incognito using handheld reflectance confocal microscopy: a paradigm shift in dermatology? Mycoses. 2015;58(6):383-6.

  19. Kye H, Kim DH, Seo SH, Ahn HH, Kye YC, Choi JE. Polycyclic annular lesion masquerading as lupus erythematosus and emerging as tinea faciei incognito. Ann Dermatol. 2015;27(3):322-5.

  20. Park YW, Choi JW, Paik SH, Kim DY, Jin SP, Park HS, et al. Tinea incognito simulating herpes simplex virus infection. Ann Dermatol. 2014;26(2):267.

  21. Liu ZH, Shen H. Tinea incognito in an old patient with bullous pemphigoid receiving topical high potency steroids. J Mycol Med. 2015;25(3):245.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Acta Pediatr Mex. 2019;40